These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12866451)

  • 1. [Recent topics on leukemia: New molecular targeting therapy].
    Hirai H
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1036-42. PubMed ID: 12866451
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel agents in acute myeloid leukemia.
    Aribi A; Ravandi F; Giles F
    Cancer J; 2006; 12(2):77-91. PubMed ID: 16630396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic principles of signal transduction].
    Yarden Y
    Onkologie; 2005 Oct; 28 Suppl 4():14-7. PubMed ID: 16205100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on the antimetastatic agents].
    Takeshima H
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():79-85. PubMed ID: 16201504
    [No Abstract]   [Full Text] [Related]  

  • 5. [New agents for solid tumours].
    Raida M
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2407-10. PubMed ID: 17054057
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibody therapeutics and apoptosis.
    Ludwig DL; Pereira DS; Zhu Z; Hicklin DJ; Bohlen P
    Oncogene; 2003 Dec; 22(56):9097-106. PubMed ID: 14663488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tyrosine kinase inhibitor STI571: new possibility in the treatment of chronic myeloid leukemia].
    Molnár L; Losonczy H
    Orv Hetil; 2002 Oct; 143(42):2379-84. PubMed ID: 12440260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibody therapy in hematology and oncology--2].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Targeting Ras related proteins for leukemia therapy].
    Kimura S; Maekawa T
    Rinsho Ketsueki; 2005 Mar; 46(3):179-86. PubMed ID: 16447712
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histone deacetylase-targeted anti-leukemia therapy].
    Ozawa Y
    Rinsho Ketsueki; 2002 Apr; 43(4):231-4. PubMed ID: 12043197
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging therapies for B-cell non-Hodgkin lymphoma.
    Briones J
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1305-16. PubMed ID: 19761434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.
    Gontarewicz A; Balabanov S; Keller G; Panse J; Schafhausen P; Bokemeyer C; Fiedler W; Moll J; Brümmendorf TH
    Leuk Res; 2008 Dec; 32(12):1857-65. PubMed ID: 18514829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
    Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.
    Tsiftsoglou AS; Bonovolias ID; Tsiftsoglou SA
    Pharmacol Ther; 2009 Jun; 122(3):264-80. PubMed ID: 19306896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal and bispecific antibodies as novel therapeutics.
    Booy EP; Johar D; Maddika S; Pirzada H; Sahib MM; Gehrke I; Loewen S; Louis SF; Kadkhoda K; Mowat M; Los M
    Arch Immunol Ther Exp (Warsz); 2006; 54(2):85-101. PubMed ID: 16648969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Future perspectives. From basic research to the development of new therapies aimed at the inhibition of the different stages of signal transduction: applications in breast cancer].
    Campone M; Kerbrat P; Roché H; Bennouna J; Cuillière JC; Le Mevel B; Fumoleau P
    Bull Cancer; 2003 Oct; 90(10):851-64. PubMed ID: 14706914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular targeting drugs].
    Ishikawa K
    Nihon Jinzo Gakkai Shi; 2012; 54(5):561-73. PubMed ID: 22991834
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell surface antigen and molecular targeting in the treatment of hematologic malignancies.
    Countouriotis A; Moore TB; Sakamoto KM
    Stem Cells; 2002; 20(3):215-29. PubMed ID: 12004080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.
    Lage A; Crombet T; González G
    Ann Med; 2003; 35(5):327-36. PubMed ID: 12952019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.